ESC Congress 2019 In Review
Top advances and key clinical trials contained in this report include the results of potentially practice-changing studies:
- ISAR-REACT 5
- DAPA HF
- PARAGON HF
- COMPLETE
The feature article provides an overview of the new ESC Clinical Practice Guidelines released during the Congress on diabetes, pre-diabetes and cardiovascular diseases, acute pulmonary embolism, supraventricular tachycardia, chronic coronary syndromes (previously stable coronary artery disease) and dyslipidaemias.
Also included are articles that contain information on selected areas of cardiovascular medicine.
ESC Congress 2018 In Review
Top advances and key clinical trials contained in this report include:
- ATTR-ACT
- COMMANDER HF
- CAMELLIA-TIMI 61
- MARINER
The feature article provides an overview of the new ESC Clinical Practice Guidelines released during the congress on the diagnosis and management of syncope, the management of cardiovascular diseases during pregnancy, myocardial revascularization, and the management of arterial hypertension; and a consensus document on the fourth universal definition of myocardial infarction.
Also included are articles that contain information on selected areas of cardiovascular medicine including innovative strategies for secondary prevention and antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome.
ESC Congress 2017 In Review
ESC Congress 2017 in Review - Main edition
Top advances and key clinical trials contained in this report include:
- COMPASS
- CANTOS
- RE-DUAL PCI
- ORION-1
The feature article provides an overview of the new ESC Clinical Practice Guidelines released during the Congress, covering the management of AMI in patients who present with STEMI, the diagnosis and treatment of PADs, the management of valvular heart disease, and a focused update on dual antiplatelet therapy in patients with CAD.
Also included are articles that contain information on selected areas of cardiovascular medicine including cholesterol lowering therapy for primary and secondary prevention, a look at future therapies for heart failure, and the prevention and management of acute stroke.
This publication is supported by SERVIER
ESC Congress 2017 in Review - Focus on Arrhythmias
Top advances and key clinical trials contained in this report include:
- CASTLE AF
- IMPACT AF
- Results from the AFinder Program
The feature article takes a closer look at current and evolving treatments for AF including a hybrid ablation approach that combines the strengths and minimises the limitations of either surgical or catheter ablation alone, pulmonary vein isolation, and antiarrhythmic drug therapy.
The issue also contains articles that reflect on four decades of ICD therapy and indications for 2017, as well as the use of anticoagulant therapy for cardioversion of AF.
This publication is supported by Boehringer Ingelheim
ESC Congress 2017 in Review - Focus on CAD & ACS
Top advances and key clinical trials contained in this report include:
- COMPASS
- RE-DUAL PCI
- VALIDATE-SWEDEHEART
- DETO2X-AMI
The feature article reviews the newly released 2017 ESC Clinical Practice Guidelines for the Management of AMI in Patients Presenting with STEMI; highlighting changes from the 2012 guidelines.
The issue also contains articles that discuss the use of pharmacotherapy after STEMI and the use of P2Y12 inhibitors for the treatment of patients with ACS.
This publication is supported by Bayer AG
ESC Congress 2017 in Review - Focus on Interventions & Peripheral Circulation
Top advances and key clinical trials contained in this report include:
- COMPASS
- A subanalysis of FAME 1 and 2
- Insights from the MAUDE database
The feature article concentrates on the newly released 2017 ESC Clinical Practice Guidelines on the Diagnosis and Treatment of PADs. Changes from the 2011 guidelines include the use of a “vascular team” for multidisciplinary management, risk stratification for asymptomatic carotid disease, and a focus on lower extremity disease.
The issue also contains articles explore the 2017 ESC Clinical Practice Guidelines focused update on dual antiplatelet therapy, and the management of PAD patients who also have concomitant cardiac diseases, including CAD, atrial fibrillation, and heart failure.
This publication is supported by Bayer AG
ESC Congress 2016 In Review
ESC Congress 2016 in Review - Main edition
The top advances and key clinical trials contained in these reports include:
- The DANISH trial
- PRAGUE-18
- ANNEXA-4
- A landmark analysis illustrating that LDL-C and systolic blood pressure have independent, multiplicative, and cumulative causal effects on the risk of CV events
The featured article provides a topline summary of the 4 new ESC Clinical Practice Guidelines on atrial fibrillation, cardiovascular disease prevention, dyslipidemia, and heart failure.
Also included are articles on new drugs being developed for the treatment of heart failure and the reversal of the effects of non-vitamin K oral anticoagulants.
ESC Congress 2016 in Review is supported by SERVIER in the form of an unrestricted educational grant.
ESC Congress 2016 in Review - Focus on Arrhythmias
The top advances and key clinical trials contained in these reports include:
- ENSURE-AF
- BEYOND NORWAY
- ORBIT-AF II
The featured article is dedicated to the 2016 ESC Clinical Practice Guidelines on Atrial Fibrillation (AF).
You will also find information on reducing the burden of AF through prevention and treatment, updates on treating AF in a complex environment, and the use of miniature leadless pacing systems.
Also included are articles on new drugs being developed for the treatment of heart failure and the reversal of the effects of non-vitamin K oral anticoagulants.
ESC Congress 2016 in Review - Focus on Arrhythmias is supported by Daiichi Sankyo Europe GmbH in the form of an unrestricted educational grant.
ESC Congress 2015 In Review
ESC Congress 2015 in Review - Main edition
Top advances and key clinical trials contained in this report include:
- Two analyses of the IMPROVE-IT study
- The TECOS trial
- The PATHWAY-2 trial
- A topline summary of the 5 new ESC Guidelines released during the Congress: pericardial diseases, ventricular arrhythmias and sudden cardiac death, pulmonary hypertension, infective endocarditis, and non–ST segment elevation acute coronary syndromes.
- The therapeutic updates on atrial fibrillation, interventional cardiology, and the clinical challenges associated with the use of anticoagulants.
ESC Congress 2015 in Review is supported by SERVIER in the form of an unrestricted educational grant.
NEW in 2015: ESC Congress 2015 in Review - Focus on Prevention
Top advances and key clinical trials contained in this report include:
- Findings from EUROASPIRE III and IV
- The SUPPORT trial
- Data from the prospective, international, cohort VISION study
- Feature articles review advances in the management of CVD risk, personalised medicine in CVD management, the role of e-cigarettes in smoking cessation, the Global Cardiovascular Nursing Leadership Forum (mobilising nurse leaders to promote prevention of CVD worldwide), and some important interventions that have been initiated in order to reach the World Heart Federation’s goal of a 25% reduction in premature deaths from CVD by 2025.
- Also included are therapeutic updates that contain in depth information on cholesterol-lowering goals and how to achieve them with statins and other treatment options, old and new.
ESC Congress in Review - Focus on Prevention is supported by Amgen
ESC Congress 2015 in Review Focus on Arrhythmias
Top advances and key clinical trials contained in this report include:
- The LEADLESS II trial of a self-contained leadless cardiac pacemaker
- The BELIEF study
- The EAST-AF Trial
- AEGEAN trial of a proactive education program to encourage patient adherence
- Feature articles look at the use of catheter ablation in AF and explore clinical guidelines for pacing, implantable cardioverter defibrillators, and cardiac resynchronization therapy.
- Also included are therapeutic updates that contain in depth information on practical issues related to leadless, subcutaneous, and wearable ICDs, and address clinical questions around the use of novel oral anticoagulants for stroke prevention in patients with nonvalvular AF.
ESC Congress in Review - Focus on Arrhythmias is supported by Daiichi Sankyo Europe GmbH in the form of an unrestricted educational grant.
ESC Congress 2014 In Review
Read the full report here
View the table of contents here
New in 2014: ESC Congress in Review - Focus on Arrhythmias
Read the full report here
View the table of contents here
EHRA EUROPACE-CARDIOSTIM 2015 In Review
Top advances and key clinical trials contained in this report include:
- Summaries of two studies of the leadless Micra Transcatheter Pacing System,
- The prospective CARDIO-FIT study, and
- Two registry studies that examined the use of NOAC use in patients with AF undergoing radiofrequency catheter ablation.
EHRA EUROPACE-CARDIOSTIM 2015 in Review is supported by Daiichi Sankyo Europe GmbH in the form of an unrestricted educational grant.
Our mission: To reduce the burden of cardiovascular disease.